Annual ROE
-49.80%
+83.30%+62.58%
December 31, 2023
Summary
- As of February 7, 2025, GLMD annual return on equity is -49.80%, with the most recent change of +83.30% (+62.58%) on December 31, 2023.
- During the last 3 years, GLMD annual ROE has risen by +15.36% (+23.57%).
- GLMD annual ROE is now -105.56% below its all-time high of 896.21%, reached on December 31, 2013.
Performance
GLMD ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-44.49%
-0.89%-2.04%
September 30, 2024
Summary
- As of February 7, 2025, GLMD quarterly return on equity is -44.49%, with the most recent change of -0.89% (-2.04%) on September 30, 2024.
- Over the past year, GLMD quarterly ROE has increased by +14.02% (+23.96%).
- GLMD quarterly ROE is now -104.96% below its all-time high of 896.21%, reached on December 31, 2013.
Performance
GLMD Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
GLMD ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +62.6% | +24.0% |
| 3 y3 years | +23.6% | +24.0% |
| 5 y5 years | -162.0% | +24.0% |
GLMD ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +62.6% | -2.0% | +55.2% |
| 5 y | 5-year | -70.0% | +62.6% | -70.5% | +55.2% |
| alltime | all time | -105.6% | +62.6% | -105.0% | +68.5% |
Galmed Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -44.49%(+2.0%) |
| Jun 2024 | - | -43.60%(-9.6%) |
| Mar 2024 | - | -48.22%(-9.4%) |
| Dec 2023 | -49.80%(-62.6%) | -53.20%(-9.1%) |
| Sep 2023 | - | -58.51%(-33.7%) |
| Jun 2023 | - | -88.27%(+0.7%) |
| Mar 2023 | - | -87.62%(-9.0%) |
| Dec 2022 | -133.10%(+25.0%) | -96.25%(-3.1%) |
| Sep 2022 | - | -99.33%(+12.3%) |
| Jun 2022 | - | -88.45%(+2.4%) |
| Mar 2022 | - | -86.39%(+10.5%) |
| Dec 2021 | -106.46%(+63.4%) | -78.17%(-0.4%) |
| Sep 2021 | - | -78.52%(+11.4%) |
| Jun 2021 | - | -70.46%(+17.4%) |
| Mar 2021 | - | -60.03%(+15.7%) |
| Dec 2020 | -65.16%(+122.5%) | -51.89%(+19.9%) |
| Sep 2020 | - | -43.28%(+20.4%) |
| Jun 2020 | - | -35.96%(+14.3%) |
| Mar 2020 | - | -31.47%(+20.6%) |
| Dec 2019 | -29.29% | -26.10%(+36.3%) |
| Sep 2019 | - | -19.15%(+34.0%) |
| Jun 2019 | - | -14.29%(+16.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -12.23%(-12.1%) |
| Dec 2018 | -19.01%(-79.2%) | -13.92%(-38.1%) |
| Sep 2018 | - | -22.49%(-48.5%) |
| Jun 2018 | - | -43.67%(-62.1%) |
| Mar 2018 | - | -115.35%(-10.1%) |
| Dec 2017 | -91.54%(-11.9%) | -128.27%(-9.3%) |
| Sep 2017 | - | -141.38%(+8.3%) |
| Jun 2017 | - | -130.57%(-0.2%) |
| Mar 2017 | - | -130.80%(+13.6%) |
| Dec 2016 | -103.94%(+110.8%) | -115.11%(+30.2%) |
| Sep 2016 | - | -88.39%(+23.7%) |
| Jun 2016 | - | -71.47%(+35.2%) |
| Mar 2016 | - | -52.85%(+28.7%) |
| Dec 2015 | -49.30%(+70.1%) | -41.05%(+23.8%) |
| Sep 2015 | - | -33.15%(+0.7%) |
| Jun 2015 | - | -32.91%(+14.2%) |
| Mar 2015 | - | -28.83%(+10.0%) |
| Dec 2014 | -28.98%(-103.2%) | -26.20%(-69.1%) |
| Sep 2014 | - | -84.80%(+3.1%) |
| Jun 2014 | - | -82.28%(-22.2%) |
| Mar 2014 | - | -105.77%(-111.8%) |
| Dec 2013 | 896.21%(+463.2%) | 896.21% |
| Dec 2012 | 159.12% | - |
FAQ
- What is Galmed Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals annual ROE year-on-year change?
- What is Galmed Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals quarterly ROE year-on-year change?
What is Galmed Pharmaceuticals annual return on equity?
The current annual ROE of GLMD is -49.80%
What is the all time high annual ROE for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high annual return on equity is 896.21%
What is Galmed Pharmaceuticals annual ROE year-on-year change?
Over the past year, GLMD annual return on equity has changed by +83.30% (+62.58%)
What is Galmed Pharmaceuticals quarterly return on equity?
The current quarterly ROE of GLMD is -44.49%
What is the all time high quarterly ROE for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high quarterly return on equity is 896.21%
What is Galmed Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, GLMD quarterly return on equity has changed by +14.02% (+23.96%)